Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine.

Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine.

Item
http://www.wikidata.org/entity/Q47445129
Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depressionKetamine's antidepressant action: beyond NMDA receptor inhibitionIntake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune ActivationRisks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites.Short- and long-term antidepressant effects of ketamine in a rat chronic unpredictable stress model.Ketamine: differential neurophysiological dynamics in functional networks in the rat brainPossible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression.Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity.Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.5-Hydroxytryptamine-independent antidepressant actions of (R)-ketamine in a chronic social defeat stress model.Beyond Ketamine: New Approaches to the Development of Safer Antidepressants.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.Lack of Antidepressant Effects of Low-Voltage-Sensitive T-Type Calcium Channel Blocker Ethosuximide in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine
P2860

Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine.

Item
http://www.wikidata.org/entity/Q47445129
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Loss of parvalbumin-immunoreac ...... sketamine, but not R-ketamine.
@en
Loss of parvalbumin-immunoreac ...... sketamine, but not R-ketamine.
@nl
type
label
Loss of parvalbumin-immunoreac ...... sketamine, but not R-ketamine.
@en
Loss of parvalbumin-immunoreac ...... sketamine, but not R-ketamine.
@nl
prefLabel
Loss of parvalbumin-immunoreac ...... sketamine, but not R-ketamine.
@en
Loss of parvalbumin-immunoreac ...... sketamine, but not R-ketamine.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P50
P577
P698
P356
P1433
P1476
Loss of parvalbumin-immunoreac ...... esketamine, but not R-ketamine
@en
P2093
P304
P31
P356
10.1016/J.PSYCHRES.2016.03.034
P407
P478
P50
P577
P698